Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Locarnini

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Journal of Hepatology|February 22, 2011
The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathwayTali Lang, Camden Lo, Narelle Skinner, et al.
Journal of Hepatology|April 21, 2019
Update of the statements on biology and clinical impact of occult hepatitis B virus infectionGiovanni Raimondo, Stephen Locarnini, Teresa Pollicino, et al.
Hepatology International|September 6, 2015
Essential components in developing public policy to control viral hepatitis: lessons from TaiwanJack Wallace, Marian Pitts, Stephen Locarnini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2017
Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B TherapeuticsTimothy M Block, Stephen Locarnini, Brian J McMahon, et al.
Journal of Hepatology|July 13, 2004
Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific regionMohammed S Jazayeri, Ashraf A Basuni, Graham Cooksley, et al.
The Journal of Infectious Diseases|September 2, 2015
CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated ChimpanzeesJolanta Rybczynska, Katherine Campbell, Saleem Kamili, et al.
The American Journal of Gastroenterology|May 11, 2002
Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia majorWilliam Sievert, Stephen Pianko, Shernyne Warner, et al.
Virology|November 22, 2016
Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosisDanielle Colledge, Sally Soppe, Lilly Yuen, et al.
Gut|November 29, 2014
Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis BMichelle Giles, Kumar Visvanathan, Sharon Lewin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 3, 2003
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failureAnna Ayres, Angeline Bartholomeusz, George Lau, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|February 22, 2011
The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathwayTali Lang, Camden Lo, Narelle Skinner, et al.
Journal of Hepatology|April 21, 2019
Update of the statements on biology and clinical impact of occult hepatitis B virus infectionGiovanni Raimondo, Stephen Locarnini, Teresa Pollicino, et al.
Hepatology International|September 6, 2015
Essential components in developing public policy to control viral hepatitis: lessons from TaiwanJack Wallace, Marian Pitts, Stephen Locarnini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2017
Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B TherapeuticsTimothy M Block, Stephen Locarnini, Brian J McMahon, et al.
Journal of Hepatology|July 13, 2004
Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific regionMohammed S Jazayeri, Ashraf A Basuni, Graham Cooksley, et al.
The Journal of Infectious Diseases|September 2, 2015
CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated ChimpanzeesJolanta Rybczynska, Katherine Campbell, Saleem Kamili, et al.
The American Journal of Gastroenterology|May 11, 2002
Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia majorWilliam Sievert, Stephen Pianko, Shernyne Warner, et al.
Virology|November 22, 2016
Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosisDanielle Colledge, Sally Soppe, Lilly Yuen, et al.
Gut|November 29, 2014
Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis BMichelle Giles, Kumar Visvanathan, Sharon Lewin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 3, 2003
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failureAnna Ayres, Angeline Bartholomeusz, George Lau, et al.
Pageof 14